The CDKN2 gene alterations in various types of adult T-cell leukaemia

British Journal of Haematology

Volumn 94, Issue 4, 1996, Pages 665-670

  Uchida, Toshiki ^a   Kinoshita, Tomohiro ^a   Watanabe, Takashi ^a   Nagai, Hirokazu ^a   Murate, Takashi ^a   Saito, Hidehiko ^a   Hotta, Tomomitsu ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

Author keywords

Adult T cell leukaemia; CDKN2; Disease progression; Homozygous deletion; P16(INK4A) MTS1 gene; Point mutation

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GENE MUTATION; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0029758396     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1841.x     Document Type: Article

References (33)

1. Amemiya, Y. & Miyahara, J. (1988) Imaging plate illuminates many fields. Nature, 336, 89-90.
2. Cairns, P., Polascik, T.J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J.L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K.R., Hedrick, L., Bova, G.S., Isaacs, W., Koch, W., Schwab, D. & Sidransky, D. (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genetics, 11, 210-212.
3. Cayuela, J.M., Madani, A., Sanhes, L., Stern, M.H. & Sigaux, F. (1996) Multiple tumour-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood, 87, 2180-2186.
4. Franchini, G. (1995) Molecular mechanisms of human T-cell leukemia/lymphotrophic virus type I infection. Blood, 86, 3619-3639.
5. INK4B gene deletions in primary leukemias. Blood, 86, 311-315.
6. Hatta, Y., Hirama, T., Miller, C.W., Yamada, Y., Tomonaga, M. & Koeffler, H.P. (1995) Homozygous deletions of p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood, 85, 2699-2704.
7. Hirama, T. & Koeffler, H.P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
8. Ichikawa, A., Hotta, T., Takagi, N., Tsushita, K., Kinoshita, T., Nagai, H., Murakami, Y., Hayashi, K. & Saito, H. (1992) Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood, 79, 2701-2707.
9. Iolascon, A., Faienza, M.F., Coppola, B., Ragione, F.D., Santoro, N. & Schettini, F. (1995) High frequency of homozygous deletions CDK4I gene in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 91, 647-651.
10. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, R.S., III. Johnson, B.E. & Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
11. Koduru, P.R.K., Zariwala, M., Soni, M., Gong, J.Z., Xiong, Y. & Broome, J.D. (1995) Deletion of cyclin-dependent kinase 4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma. Blood, 86, 2900-2905.
12. Kundson, A.G., Hethcote, H.W. & Brown, B.W. (1975) Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America, 72, 5116-5120.
13. Kyritsis, A.P., Zhang, B., Zhang, W., Xiao, M., Takeshima, H., Bondy, M.L., Cunningham, J.E., Levin, V.A. & Bruner, J. (1996) Mutations of p16 gene in gliomas. Oncogene, 12, 63-67.
14. Majello, B., Kenyon, L.C. & Dalla-Favera, R. (1986) Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus. Proceedings of the National Academy of Sciences of the United States of America, 83, 9636-9640.
15. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. & Sidransky, D. (1995) 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine, 1, 686-692.
16. Meyerson, M. & Harlow, E. (1994) Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Molecular and Cellular Biology, 14, 2077-2086.
17. Nakamaki, T., Kawamata, N., Schwaller, J., Tobler, A., Fey, M., Pakkala, S., Lee, Y.Y., Kim, B.K., Fukuchi, K., Tsuruoka, N., Kahan, J., Miller, C.W. & Koeffler, H.P. (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16, p18 in myeloid leukaemias. British Journal of Haematology, 91, 139-149.
18. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R. & Hirai, H. (1995) Loss of the cyclin-dependent kinase 4-inhibitor (p16: MTS1) gene is frequent in highly specific to lymphoid tumours in primary human hematopoietic malignancies. Blood, 86, 1548-1556.
19. Ohashi, H., Ichikawa, A., Takagi, N., Hotta, T., Naoe, T., Ohno, R. & Saito, H. (1992) Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone. Leukemia, 6, 859-862.
20. Ohnishi, H., Kawamura, M., Ida, K., Sheng, X.M., Hanada, R., Nobori, T., Yamamori, S. & Hayashi, Y. (1995) Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood, 86, 1269-1275.
21. INK4B/MTS2 in human leukemias and lymphomas. Cancer Research, 55, 1436-1440.
22. Quelle, D.E., Zindy, F., Ashmun, R.A. & Sherr, C.J. (1995) Alternative reading frames of the INK4a tumour suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
23. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J.L., Bauters, F., Wattel, E. & Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
24. Schröder, M., Mathieu, U., Dreyling, M.H., Bohlander, S.K., Hagemeijer, A., Beverloo, B.H., Olopade, O.I., Stilgenbauer, S., Fischer, K., Bentz, M., Lichter, P. & Döhner, H. (1995) CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B-and T-cell origin but is frequent in acute lymphoblastic leukaemia. British Journal of Haematology, 91, 865-870.
25. Serra, A., Gottardi, E., Ragione, F.D., Saglio, G. & Iolascon, A. (1995) Involvement of the cyclin-dependent kinnse-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia. British Journal of Haematology, 91, 625-629.
26. Serrano, M., Hannon, G.J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK4. Nature, 366, 704-707.
27. Sherr, C.J. & Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes and Development, 27, 1149-1163.
28. Shimoyama, M. (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: a report from the lymphoma study group (1984-87). British Journal of Haematology, 79, 428-437.
29. Siebert, R., Willers, C.P., Schramm, A., Fossa, A., Dresen, I.M.G., Uppenkamp, M., Nowrousian, M.R., Seeber, S. & Opalka, B. (1995) Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. British Journal of Haematology, 91, 350-354.
30. INK4A) gene in primary B-cell lymphomas. Blood, 86, 2724-2731.
31. Uchiyama, T., Yodoi, J., Segawa, K., Takatsuki, K. & Uchino, H. (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood, 50, 481-492.
32. Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T. & Saito, H. (1994) The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood, 84, 3158-3165.
33. Yoshida, M., Seiki, M., Yamayuchi, K. & Takatsuki, K. (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumours of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proceedings of the National Academy of Sciences of the United States of America, 81, 2534-2537.